PTHS
Price:
$27.5
Market Cap:
$17.83M
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
Industry
Biotechnology
IPO Date
2025-07-02
Stock Exchange
AMEX
Ticker
PTHS
According to Pelthos Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.20. This represents a change of 30.13% compared to the average of -0.92 of the last 4 quarters.
The mean historical PE Ratio of Pelthos Therapeutics Inc. over the last ten years is -4.61. The current -1.20 PE Ratio has changed 2.50% with respect to the historical average. Over the past ten years (40 quarters), PTHS's PE Ratio was at its highest in in the September 2025 quarter at -0.28. The PE Ratio was at its lowest in in the March 2026 quarter at -1.70.
Average
-4.61
Median
-2.06
Minimum
-11.43
Maximum
-0.87
Discovering the peaks and valleys of Pelthos Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.40%
Maximum Annual PE Ratio = -0.87
Minimum Annual Increase = -75.78%
Minimum Annual PE Ratio = -11.43
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.35 | 54.40% |
| 2024 | -0.87 | -5.47% |
| 2023 | -0.92 | -66.69% |
| 2022 | -2.77 | -75.78% |
| 2021 | -11.43 | 10.95% |
The current PE Ratio of Pelthos Therapeutics Inc. (PTHS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.05
5-year avg
-3.47
10-year avg
-4.61
Pelthos Therapeutics Inc.’s PE Ratio is less than CASI Pharmaceuticals, Inc. (-0.07), greater than Lisata Therapeutics, Inc. (-1.96), less than Clearside Biomedical, Inc. (-0.06), greater than Kairos Pharma, Ltd. (-1.58), greater than Lexaria Bioscience Corp. (-1.58), less than Passage Bio, Inc. (-0.49), greater than Lixte Biotechnology Holdings, Inc. (-9.27), less than Enlivex Therapeutics Ltd. (0.02), less than MetaVia Inc. (-0.64), less than Cingulate Inc. (-0.96),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.07 | $2.33M | |
| -1.96 | $32.42M | |
| -0.06 | $2.15M | |
| -1.58 | $9.42M | |
| -1.58 | $12.56M | |
| -0.49 | $18.64M | |
| -9.27 | $71.84M | |
| 0.02 | $16.29M | |
| -0.64 | $3.83M | |
| -0.96 | $27.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pelthos Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pelthos Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pelthos Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Pelthos Therapeutics Inc. (PTHS)?
What is the highest PE Ratio for Pelthos Therapeutics Inc. (PTHS)?
What is the 3-year average PE Ratio for Pelthos Therapeutics Inc. (PTHS)?
What is the 5-year average PE Ratio for Pelthos Therapeutics Inc. (PTHS)?
How does the current PE Ratio for Pelthos Therapeutics Inc. (PTHS) compare to its historical average?